$MRNA - LongNASDAQ:MRNA - I'm going long here. Maybe it will get some love with a health care push.
LONG
not trading advice. :)
Moderna, Inc. Shs Cert Deposito Arg Repr 0.0526315789 Shs
No trades
Key facts today
−0.315 USD
−3.16 B USD
2.87 B USD
About Moderna, Inc.
Sector
Industry
CEO
Stéphane Bancel
Website
Headquarters
Cambridge
Founded
2010
Identifiers
2
ISINAR0666228538
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.
Related stocks
Double bottom with potential doubling!The price appears to have found a bottom at $23.2, and the high trading volume suggests growing interest from major investors.
The current pattern is a double bottom with a neckline at $35.6 (black line). A breakout above this level could target the resistance at $48.9 (blue line).
On Friday, the
$MRNAEither the price breaks out of the trendline and hit target at 33.97 or price rejects at the trendline and dip down lower to 23.89 or all the way down to 19.31 which will then create a descending wedge.
$MRNA: campaign trading started# Moderna’s Major Collaborations
## Co-Development and Research Partnerships
- Merck & Co.: Joint development of personalized cancer vaccine mRNA-4157, combining Moderna’s mRNA platform with Merck’s KEYTRUDA® immunotherapy.
- AstraZeneca: Collaboration on RSV vaccine mRNA-1345, advancing Phase 3
$MRNA I might full port..Everything is noted in the chart for visualization. We have local resistance around $27 which I don't think is an issue. This name is at 5 year lows with an incredible 67% haircut over the span of a year and change, if that. NASDAQ:MRNA just crushed its last earnings beat and it dropped. A control
Infection year 2025; rounded bottoming formation.- Infection year 2025; rounded bottoming formation.
- business is improving starting 2025
MRNA: Bullish Setup Ahead of Earnings & FOMCMRNA: Bullish Setup Ahead of Earnings & FOMC
Moderna (MRNA) appears to have found a bottom near $23.50, based on recent price behavior. Following that level, the stock began accumulating, suggesting renewed buying interest. This was confirmed when MRNA decisively broke above $28.50, signaling a sh
Bullish Analysis for Moderna (MRNA)Recent Price Action Shows Strength MRNA has shown significant bullish momentum since mid-May 2025, rising from around $24 to current levels above $34, representing a 40%+ gain. The stock has formed a series of higher lows and higher highs, establishing a clear uptrend.
Key Bullish Factors:
Positiv
MRNA Approaching Trend Shift After Multi-Month DeclinePotential trend flip on the Moderna Chart for the first time since May 2024. I use a default doubled cloud on the daily timeframe 18/52/104/26. I find this to be superior to the default cloud on both backtesting and forward testing over the past decade on any chart.
Ideal bullish entry conditions
Retest comingBullish flag forming to test the ~$35 resistance again. Earnings coming up on 08/01. I expect the flag breakout before earnings. I have calls exp 08/01 strike 31.5. SL triggers if a daily candle breaks down the support area and closes below 30.30.
See all ideas
Curated watchlists where MRNAC is featured.
